Phase I Study to Evaluate the Safety and Efficacy of MF101 as Well as the Pharmacokinetics of Its Key Active Components
Clinical trial NCT00453297 · TERMINATED
Trial details
- NCT number
- NCT00453297
- Sponsor
- Bionovo
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.